KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Capital Expenditures (2016 - 2025)

HCA Healthcare (HCA) has disclosed Capital Expenditures for 15 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 15.88% to $1.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.9 billion, a 1.42% increase, with the full-year FY2025 number at $4.9 billion, up 1.42% from a year prior.
  • Capital Expenditures was $1.5 billion for Q4 2025 at HCA Healthcare, up from $1.3 billion in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.5 billion in Q4 2025 to a low of $654.0 million in Q1 2021.
  • A 5-year average of $1.1 billion and a median of $1.2 billion in 2023 define the central range for Capital Expenditures.
  • Biggest YoY gain for Capital Expenditures was 81.8% in 2021; the steepest drop was 23.33% in 2021.
  • HCA Healthcare's Capital Expenditures stood at $1.2 billion in 2021, then increased by 10.99% to $1.3 billion in 2022, then decreased by 12.4% to $1.2 billion in 2023, then increased by 10.87% to $1.3 billion in 2024, then grew by 15.88% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for HCA's Capital Expenditures are $1.5 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.2 billion (Q2 2025).